PeDRA 2025Abstract 014
Antibodies targeting OX40 and OX40L for the treatment of atopic dermatitis have unique inhibitory mechanisms
Nolden K, Shi Y, Bunick C
PeDRA Annual Conference 2025Minneapolis, 9–11 Oct 2025 · published in JID 9 Mar 2026
Topics: Atopic dermatitis & eczema
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/s0022-202x(26)00555-5 · Not in PubMed: details from Crossref